Prescription ID | TCMF3207 |
Pinyin Name | Geng Nian Ning |
Chinese Name | 更年宁 |
English Name | Geng Nian Ning |
Function Description | 眩晕, 不寐, 月经失调, 绝经前后诸症 |
Indications | Menopausal disorder, Vertigo disorder, Insomnia disorder, Climacteric states |
Disease ICD-11 Category |
SB95 [Menopausal disorder (TM1), 绝经前后诸症 (TM1)
]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; GA30.00 [Menopausal or female climacteric states, 更年期或女性更年期状态 ]; |
Human Tissues Associated with Indication | Brain, Uterus |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH228 | Bupleurum chinense | 柴胡 | TCMH228 | ITSAM2218-14 |
TCMH986 | Scutellaria baicalensis | 黄芩 | TCMH986 | ITSAP4211-14 |
TCMH104 | Paeonia lactiflora | 白芍 | TCMH104 | ITSAH2416-14 |
TCMH1503 | Eclipta prostrata | 墨旱莲 | TCMH1503 | ITSAP4516-14 |
TCMH1721 | Panax ginseng | 人参 | TCMH1721 | GBVE1679-11 |
TCMH426 | Codonopsis pilosula | 党参 | TCMH426 | ITSAL4530-14 |
TCMH2532 | Curcuma aromatica | 郁金 | TCMH2532 | ITSAF2298-14 |
TCMH2265 | Cyperus rotundus | 香附 | TCMH2265 | GENG1049-15 |
TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
TCMH188 | Mentha haplocalyx | 薄荷 | TCMH188 | HM595443 |
TCMH305 | Cnidium officinale | 川芎 | TCMH305 | ITSAP4207-14 |
TCMH2343 | Scrophularia ningpoensis | 玄参 | TCMH2343 | ITSAO4295-14 |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH552 | Rhizoma pinelliae preparata | 法半夏 | TCMH552 | |
TCMH1920 | Acorus tatarinowii | 石菖蒲 | TCMH1920 | ITSAI4409-14 |
TCMH1513 | Paeonia moutan | 牡丹皮 | TCMH1513 | |
TCMH243 | Pericarpium citri reticulatae | 陈皮 | TCMH243 | |
TCMH1059 | Glycine max | 姜 | TCMH1059 | ITSAJ4675-14 |
TCMH120 | Atractylodes macrocephala | 白术 | TCMH120 | ITSAN4430-14 |
TCMH407 | Salvia miltiorrhiza | 丹参 | TCMH407 | ITSAH2408-14 |
TCMH2161 | Vaccaria segetalis | 王不留行 | TCMH2161 | |
TCMH1597 | Ligustrum lucidum | 女贞子 | TCMH1597 | ITSAM2109-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT107 | GRIK2 | Glutamate receptor ionotropic kainate 2 | Ion channel | Q13002 |
TCMT109 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | Ion channel | P42262 |
TCMT110 | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | Ion channel | P48058 |
TCMT111 | GRIK5 | Glutamate receptor ionotropic kainate 5 | Ion channel | Q16478 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
Target ID | Target Name |
---|---|
TCMT1168 | Trichomonas vaginalis |
TCMT1170 | Enterobacter cloacae |
TCMT1172 | Staphylococcus aureus subsp. aureus RN4220 |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1189 | Pseudomonas fluorescens |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0000187 | activation of MAPK activity | GRM1, INSR, MAP2K1, MAP3K7, PIK3CB, PTPN1 | 2.08447 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC | 3.24427 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTAFR, PTGES, PTGS2, RELA, SLC6A4, SRC | 4.41764 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, EGFR, MMP2, MMP9, TEK | 2.53719 |
[BP] GO:0001504 | None | SLC1A1, SLC6A2, SLC6A4 | 2.23792 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, EGFR, GRIK5, INSR, MAOA, PTGS2, SLC1A1, SLC6A2, SLC6A4, SMAD3 | 4.52615 |
[BP] GO:0001516 | None | PTGES, PTGS1, PTGS2 | 2.53719 |
[BP] GO:0001666 | response to hypoxia | ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT | 3.65822 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 | 9.46683 |
[BP] GO:0001775 | cell activation | ADRA2A, ALOX5, APP, AXL, EGFR, F2, FLT3, FUT7, HSPA1A, MMP9, PIK3CA, PIK3CB, PTAFR, RORC, SMAD3, SRC | 2.23106 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.5702 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | MAP2K1, PIK3CA, FLT3, PIM1, PIK3CB, RELA | 5.2283 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MAP3K7, MET, EGFR, IGF1R | 7.945 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA, RELA | 1.0701 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, CACNA1C, PIK3CB | 1.1278 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, PIK3CA, MMP2, PIM1, PIK3CB, F3, RELA | 4.9855 |
Alcoholism_Homo sapiens_hsa05034 | MAP2K1, MAOA | 0.5113 |
Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | CACNA1C | 0.392 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | PIK3CA, INSR, PIK3CB | 2.5251 |
Alzheimer's disease_Homo sapiens_hsa05010 | APP, CACNA1C | 0.5399 |